Chemical Structure (Buprenorphine 01)
Buprenorphine And Naloxone Tablet
Product Images NDC 71335-2828
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 71335-2828). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Buprenorphine 02)
Image (Buprenorphine 03)
Label (Lbl713352828)
Each sublingual tablet contains 8.62 mg of buprenorphine hydrochloride (equivalent to 8 mg buprenorphine base) and 2.44 mg of naloxone hydrochloride dihydrate (equivalent to 2 mg naloxone base). This medication is used for treating opioid dependence. It is important to keep this product out of reach of children, as accidental ingestion could be harmful and require immediate medical attention. The tablets are identifiable by being debossed with "RP" on one side and "n8" on the other side. It is essential to follow the dosage instructions provided by the pharmacist. The tablets are stored at room temperature between 20°C to 25°C (68°F to 77°F). It is recommended to refer to the package insert for full prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
